Lixte Biotechnology Holdings Inc (NASDAQ: LIXT) is 18.53% higher on its value in year-to-date trading and has touched a low of $0.64 and a high of $4.25 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LIXT stock was last observed hovering at around $2.53 in the last trading session, with the day’s gains setting it 0.22%.
Currently trading at $2.75, the stock is 102.22% and 107.06% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.24 million and changing 8.70% at the moment leaves the stock 66.06% off its SMA200. LIXT registered 35.49% gain for a year compared to 6-month loss of 18.03%. The firm has a 50-day simple moving average (SMA 50) of $1.3282 and a 200-day simple moving average (SMA200) of $1.6562.
The stock witnessed a 106.80% gain in the last 1 month and extending the period to 3 months gives it a 150.00%, and is 133.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 46.35% over the week and 27.04% over the month.
Lixte Biotechnology Holdings Inc (LIXT) has around 2 employees, a market worth around $7.38M and $0.00M in sales. Distance from 52-week low is 329.69% and -35.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-286.78%).
11.0 institutions hold shares in Lixte Biotechnology Holdings Inc (LIXT), with institutional investors hold 19.42% of the company’s shares. The shares outstanding are 2.68M, and float is at 2.08M with Short Float at 0.21%. Institutions hold 15.84% of the Float.
